1607PDImmune response, safety, and overall survival of NY-ESO-1+ soft tissue sarcoma patients treated with CMB305 therapy. (23rd October 2018) - Chawla, S P; Pollack, S; Block, M; Druta, M; Do, K; Morris, J C; Kim, J W; Bohac, C; Lu, H; Gnjatic, S; Jones, R L; Hwu, P; et al.